Greater than 18,000 doses of Nuvaxovid COVID-19 vaccine administered in Singapore, 5 stories of extreme reactions

SINGAPORE: Greater than 18,000 doses of Novavax’s Nuvaxovid COVID-19 vaccine have been administered as of Aug 31, with 5 circumstances of extreme uncomfortable side effects reported.

In its thirteenth vaccine security report on Monday (Sep 19), the Well being Sciences Authority stated there have been 28 stories of opposed reactions, of which 82 per cent – or 23 circumstances – weren’t severe.

This included allergic reactions corresponding to rash and eye swelling, numbness, irritation of blood vessels, dizziness and chest ache.

“These have been largely in keeping with what have been reported within the medical research or with different COVID-19 vaccines,” HSA stated. Frequent uncomfortable side effects that recipients could expertise embrace injection web site ache and/or tenderness, fatigue, headache and muscle ache.

HSA granted interim authorisation to the Nuvaxovid COVID-19 vaccine to be used in people aged 18 and above in February, below the Pandemic Particular Entry Route. Singapore started administering the vaccine to the general public on Might 18.

5 circumstances of extreme uncomfortable side effects have been reported as of Aug 31, together with 4 circumstances of anaphylaxis and one case of a severe allergic response.

“These occurred in inclined people who had earlier allergic reactions or opposed results to Pfizer/Comirnaty and Sinovac-CoronaVac COVID-19 vaccines, in addition to a historical past of drug or meals allergic reactions,” HSA added.

“All of the sufferers have recovered from the intense opposed reactions.”